843 - Myth: Trimethoprim-Sulfamethoxazole Is Not Effective for the Treatment of Skin and Soft Tissue Infections Involving Beta-Hemolytic Streptococci

Friday, October 21, 2022

10:55 AM – 11:20 AM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Sarah B. Doernberg, MD, MAS

Associate Professor
University of California, San Francisco
San Francisco, California, United States

Disclosure: Disclosure(s): Basilea: Advisor/Consultant (); Genentech: Advisor/Consultant (); Gilead: Grant/Research Support (); Johnson and Johnson: Advisor/Consultant (); NIH: Grant/Research Support (); Regeneron: Grant/Research Support ()

Disclosure(s):

Sarah B. Doernberg, MD, MAS: Basilea: Advisor/Consultant (); Genentech: Advisor/Consultant (); Gilead: Grant/Research Support (); Johnson and Johnson: Advisor/Consultant (); NIH: Grant/Research Support (); Regeneron: Grant/Research Support ()